中文
Announcement
More
Progress in Chemistry 2005, Vol. 17 Issue (05): 916-923 Previous Articles   Next Articles

• Review •

Advances in L-Nucleosides as Anti-HIV and Anti-HBV Agents

Dong Chunhong1;Chang Junbiao1,2*   

  1. 1.Department of Chemistry, University of Science and Technology of China,Hefei 230027,China;

    2.The Research Center of Henan Academy of Sciences, Zhengzhou 450002,China

  • Received: Revised: Online: Published:
  • Contact: Chang Junbiao
PDF ( 1637 ) Cited
Export

EndNote

Ris

BibTeX

Drug discovery for anti-HIV, anti-HBV chemotherapy has provided the effective clinical treatment. Among these antiviral agents used in therapy, nucleoside analogues are particularly useful. In this paper, the antiviral mechanism of the nucleoside analogues, the discovery of L-nucleoside and the classificalion of some new anti-HIV, anti-HBV L-nucleoside analogues are introduced. In addition, the datum of two enantiomers of some anti-HIV, anti-HBV nucleoside analogues indicate that the bioactivities and securities of L-nucleoside analogues is superior to the counterpart enantiorners. As a result, the medicinal chemists have focused their attention on designing and preparing new L-nucleoside analogues to search for more powerful and securer new antiviral agents.

CLC Number: 

[ 1 ] Levene P A , Jacobs W A. Chem. Ber. , 1909 , 42 : 2474 —2478
[ 2 ] De Clerq E. Adv. Drug Res. , 1988 , 17 : 1
[ 3 ] Chu C K, Baker D C. Nucleosides and Nucleotides as Antitumor Agents and Antiviral Agents. New York : Plenum Press , 1993
[ 4 ] De Clerq E. J . Med. Chem. , 1995 , 38 : 2491 —2517
[ 5 ] Gumina G, Chong Y, Song G Y, Chu C K. Current Topics in Medicinal Chemistry , 2002 , 2 : 1065 —1086
[ 6 ] Lin T S , Luo M Z , Liu M C. Tetrahedron Lett . , 1994 , 35 : 3477
[ 7 ] Chu C K, Ahn S K, Kim H O , et al . Tetrahedron Lett . , 1991 ,32 : 3791
[ 8 ] Kim H O , Schinazi R F , Shanmuganathan K, et al . J . Med.Chem. , 1993 , 36 : 519
[ 9 ] Bolon P , Wang P , Chu C K, et al . Bioorg. Med. Chem. Lett . ,1996 , 6 : 1657
[10] Chang C N , Dong S L , Zhou J H , et al . J . Biol . Chem. , 1992 ,267 :13938 —13942
[11] Dong S L , Tsai C H , Schinszi R F. Proc. Natl . Acad. Sci .USA , 1991 , 8495 —8499
[12] Dienstag J L , Perrillo R P , Schiff E R , et al . New Engl . J .Med. , 1995 , 333 : 1657
[13] Chen S H , Lin S , King I , et al . Bioorg. Med. Chem. Lett . ,1998 , 8 : 3245 —3250
[14] Belleau B , Dixit D , Nguyen- Ga N , et al . International Conference on AIDS. Montreal , 1990
[15] Coates J A V , Cammack N , Jenkinson H J , et al . Antimicrob.Agent Chemother. , 1992 , 36 : 202 —205
[16] Schinazi R F , Chu C K, Peck A , et al . Antimicrob. Agent Chemother. , 1992 , 36 : 672 —676
[17] Wang P , Hong J H , Chu C K. Antiviral Res. , 1998 , 40 : 19 —44
[18] Gumina G, Song G Y, Chu C K. FEMS Microb. Lett . , 2001 ,202 : 9 —15
[19] Soudeyns H , Yao Q , Belleau B , et al . Antimicrob. Agent Chemother. , 1991 , 35 : 1386 —1390
[20] Dong S L , Tsai C H , Schinazi R F , et al . Proc. Natl . Acad.Sci . USA , 1991 , 88 : 8495
[21] Coates J A V , Cammack N , Jenkinson H J , et al . Antimicrob.Agent Chemother. , 1992 , 36 : 202 —205
[22] Beach J W, Jeong L S , Alves A J , et al . J . Org. Chem. , 1992 ,57 : 2217 —2219
[23] Chu C K, Beach J W, Jeong L S , et al . J . Org. Chem. , 1991 ,56 : 6503 —6505
[24] Boucher C A , Cammack N , Schipper P , et al . Antimicrob. Agent Chemother. , 1993 , 37 : 2231 —2234
[25] Jeong L S , Schinazi R F , Beach J W, et al . J . Med. Chem. ,1993 , 36 : 181 —195
[26] Parker W B , Cheng Y C. J . NIH Res. , 1994 , 6 : 57 —61
[27] Dienstag J L , Perrillo R P , Schiff E R , et al . New Engl . J .Med. , 1995 , 333 : 1657 —1661
[28] Severini A , Liu X Y, Wilson J S , Tyrrell D L. Antimicrob. Agent Chemother. , 1995 , 39 : 1430 —1435
[29] Schewach D S , Liotta D C , Schinazi R F. Biochem. Pharmcol . ,1993 , 45 : 1540 —1543
[30] Cammack N C , Rouse P L , Marr C L P , et al . Biochem.Pharmcol . , 1992 , 43 : 2059 —2064
[31] Furman P A , Wilson J E , Reardon J E , et al . Antiviral Chem.Chemother. , 1995 , 6 : 345 —355
[32] Schinazi R F , McMillan A , Cannon D , et al . Antimicrob. Agent Chemother. , 1992 , 36 : 2423 —2431
[33] Sommadossi J P , Schinazi R F , Chu C K, et al . Biochem.Pharmcol . , 1992 , 44 : 1921 —1925
[34] Furman P A , Davis M, Liotta D C , et al . Antimicrob. Agent Chemother. , 1992 , 36 : 2686 —2692
[35] Cui L , Schinazi R F , Gosselin G, et al . Biochem. Pharmcol . ,1996 , 52 : 1577 —1584
[36] Norbeck D W, Spanton S. Tetrahedron Lett . , 1989 , 30 : 6263 —6266
[37] Kim H O , Shanmuganathan K, Alves A J , et al . Tetrahedron Lett . , 1992 , 33 : 6899 —6902
[38] Grove KL , Guo X, Liu S H , et al . Cancer Res. , 1995 , 55 :3008 —3011
[39] Schinazi R F , McClure H M, Boudinout F D , et al . Antiviral Res. , 1994 , 23(suppl) : 81
[40] Rajagopalan P F , Boudinot F D , Chu C K, et al . Pharm. Res. ,1994 , 11( suppl) : 381
[41] Van Draannen N A , Tisadle M, Parry N R , et al . Antimicrob.Agent Chemother. , 1994 , 38 : 868 —871
[42] Faraj A , Agrofoglio L A , Wakefield J K, et al . Antimicrob.Agent Chemother. , 1994 , 38 : 2300 —2305
[43] Chong Y, Chu C K. Carbonhydr. Res. , 2002 , 337 : 397 —402
[44] Bridges B , Juodawikis A , Faraj A , et al . Antimicrob. Agents Chemother. , 2001 , 45 : 229 —235
[45] Lin Y S , Luo M Z , Liu M C , et al . J . Med. Chem. , 1996 , 39 :1757 —1759
[46] Bolon J P , Wang P Y, Chu C K, et al . Bioorg. Med. Chem.Lett . , 1996 , 6 (14) : 1657 —1662
[47] Fourel I , Hantz O , Watanabe K A , et al . Antimicro. Agents Chemother. , 1990 , 34 : 473 —475
[48] Fried M W, Dibisceglie A M, Straus S E , et al . Hepatology ,1992 , 16 : 127A
[49] Peek S F , Cote P J , Jacob J R , et al . Hepatology , 2001 , 33 :254 —266
[50] Gumina G, Song G Y, Chu C K. Antiviral Chem. Chemother. ,2001 , 12 : 89 —112
[51] Zhu Y, Yamamoto T , Cullen J , et al . J . Virol . , 2001 , 75 :311 —322
[52] Ma T W, Pai S B , Zhu YL , et al . J . Med. Chem. , 1996 , 39 :2835 —2843
[53] Ma T W, Lin J C , Newton M G, et al . J . Med. Chem. , 1997 ,40 : 2750 —2754
[54] Mellors J , Lederman M, Haas D , et al . Abstracts of 5th Conference on Retroviruses and Opportunistic Infections. Chicago ,1998
[55] Wang P Y, Schinazj R F , Chu C K. J . Med. Chem. , 1999 , 42 :3390 —3399
[56] Lee K, Chol Y, Gullen E , et al . J . Med. Chem. , 1999 , 42 :1320 —1328
[57] Pai S B , Litto D C , Chu C K, et al . Abstracts of Papers 3rd International Conference on Therapies for Viral Hepatitis. USA ,1999
[58] Pai S B , Chu C K, Litto D C , et al . Antiviral Ther. , 2000 , 5(suppl . 1) : B66
[59] Jin D Z , Kwon S H , Moon H R , et al . Bioorg. Med. Chem. ,2004 , 12 : 1101 —1109
[60] KimJ , Hong J H. Carbohydrate Res. , 2003 , 338 : 705 —710
[61] Aragonès S , Bravo F , Diaz Y, et al . Tetrahedron Lett . , 2003 ,44 : 3771 —3773
[62] Lee K, Chol Y, Gumina G, et al . J . Med. Chem. , 2002 , 45 :1313 —1320
[63] Choi Y, Choo H , Chong Y, et al . Org. Lett . , 2002 , 4 : 305 —307
[64] Pejanovic V , Stokic Z , Stojanovic B , et al . Bioorg. Med.Chem. , 2003 , 1849 —1852
[65] Chong Y, Gumina G, Chu C K. J . Med. Chem. , 2003 , 46 :3245 —3256
[66] Ugarkar B G, Castellino A G, DaRe J S , et al . J . Med. Chem. ,2003 , 46 : 4750 —4760
[67] Gumina G, Schinazi R F , Chu C K. Org. Lett . , 2002 , 4 :4177 —4180
[68] Verri A , Priori G, Spadari S , et al . Biochem. J . , 1997 , 328 :317 —320
[69] Seley K L , Stewart M G, Cheng Y C , et al . Nucleosides Nucleotides , 1999 , 18 : 807 —810

[1] Zhang Qingshan*,Guo Bingnan,Zhang Huimiao. Development and Application of Gemini Surfactants [J]. Progress in Chemistry, 2004, 16(03): 343-.